Expert Panel Affirms ‘Continued Marketing’ Of Ambrisentan, Everolimus In India

Sanofi Ends Dronedarone Sales Due To Low Commercial Interest

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".